Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

THE ROYAL WOLVERHAMPTON NHS TRUST

Home Clinical Trial Sponsors and OrganizationsTHE ROYAL WOLVERHAMPTON NHS TRUST

THE ROYAL WOLVERHAMPTON NHS TRUST

Care Of Royal Hospital, Wolverhampton, United Kingdom

Also known as:

new cross hospital

cannock chase hospital

aids helpline

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

6

5 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

3

50.0%

Phase 1

2

33.3%

Phase 4

1

16.7%

Trial Status Distribution

Active, not recruiting

5

83.3%

Completed

1

16.7%

Clinical Trials

Trials sponsored by this organization (6)

Investigating the safety and improvement of vision for patients suffering from severe keratoconus or post LASIK ectasia after treatment with the Xenia corneal lenticule

Active, not recruiting

Mar 202215 participants

A trial to assess the efficacy of a new drug versus standard care for anaemia following colorectal cancer surgery

Active, not recruiting

Feb 202242 participants

Treatment of iron deficiency anaemia in pregnancy study

Jun 2019111 participants

Optimising neonatal service provision for preterm babies born between 27 and 31 weeks of gestation in England

Active, not recruiting

Mar 201724,000 participants

The Effect of Intravenous Cangrelor vs oral Ticagrelor on Heart Muscle Damage in Patients with Major Heart Attack.

Active, not recruiting

Feb 2016100 participants

Antiplatelet therapy in the treatment of heart attacks

Active, not recruiting

Jan 201587 participants

Approvals

No approval data available

News

LivaNova Launches Essenz Perfusion System in China Following NMPA Approval

- LivaNova PLC has launched its Essenz Perfusion System in China after receiving regulatory approval from the National Medical Products Administration, targeting the world's second-largest heart-lung machine market. - The next-generation cardiopulmonary platform has supported over 100,000 patients globally since its 2023 launch and offers real-time monitoring with patient-tailored perfusion capabilities. - China represents a significant growth opportunity with 330 million individuals affected by cardiovascular disease and over 700 hospitals equipped for cardiac surgery. - The system addresses the projected 185,000 adult and 23,500 pediatric extracorporeal circulation procedures expected in China for 2025.

On this page

Overview
Clinical Trials6
Approvals
News1

Back to Organizations